Company Directory / pharmaceuticals

VivaVision Biotech logo

PrivateFor profitpharmaceuticalsChina

VivaVision Biotech

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases.

Founded
2016
10 years ago
Staff
1-10
band, as listed
Followers
-
on LinkedIn
Funding
$431M
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

1-10 people: larger than 0% of companies with a size listed

Age

201619002026

10 years old.

Reach

Website ranked #13,149,851 in the world for traffic, about 78 visits a month.

What it does

Biotechnology

Funding, as listed

$431M currency not stated

  • Rounds5
  • LatestSeries d, May 2023
  • Investors19, 3 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersWang Shen

Every detail we hold

Everything the source datasets list about VivaVision Biotech, field by field. Contact details are held but never shown.

The company

Name
VivaVision Biotech
Type
For profit
Status
Private
Founded
2016
Founders
Wang Shen
Industry
pharmaceuticals
Categories
Biotechnology

Where

Country
China
Markets
Asia-Pacific (APAC)

Size and reach

Staff band
1-10
Web traffic rank
#13,149,851
Monthly web visits
78

Funding, as listed

Total
431,000,000 (currency not stated)
Rounds
5
Latest round
Series d
Latest round date
May 2023
Investors
19
Lead investors
3
Listing status
private

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

VivaVision Biotech may be growing as it has been identified as an innovative ophthalmic drug company, suggesting active research and development in its field. The company is mentioned alongside other key companies in the open-angle glaucoma market, indicating its relevance in a specific therapeutic area. Furthermore, the mention of VivaVision Biotech in the context of the ocular hypertension market, which is expected to grow due to an aging population, implies that the company is operating in a market with potential for expansion.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

pharmaceuticals in China.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 38,667 companies in China and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.